The 65-year-old European had ignored his urinary issues and also the blood in urine. And then there was intermittent fever. After prolonged exposure to sub-zero temperatures, he came to India for ...
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ (120mg vial), denosumab biosimilars ...
Nationally, about 208 Black men per 100,000 died from cancer, as opposed to 179 per 100,000 white men, the study said. About ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback